Aspen Aerogels (NYSE:ASPN - Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of ($0.13) per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.11. The business had revenue of $84.22 million during the quarter, compared to analysts' expectations of $83.82 million. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. During the same quarter last year, the business posted ($0.20) EPS. On average, analysts expect Aspen Aerogels to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Aspen Aerogels Price Performance
NYSE ASPN remained flat at $16.63 during trading on Wednesday. The company's stock had a trading volume of 652,819 shares, compared to its average volume of 963,928. The firm has a market capitalization of $1.28 billion, a P/E ratio of -25.21 and a beta of 2.04. The company has a 50-day moving average of $16.57 and a 200-day moving average of $13.21. The company has a quick ratio of 2.91, a current ratio of 3.41 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a fifty-two week low of $5.32 and a fifty-two week high of $19.10.
Analyst Ratings Changes
ASPN has been the subject of several research analyst reports. Canaccord Genuity Group raised their price target on Aspen Aerogels from $13.00 to $17.00 and gave the company a "buy" rating in a report on Wednesday, December 27th. Roth Mkm started coverage on Aspen Aerogels in a report on Wednesday, March 6th. They issued a "buy" rating and a $22.00 target price for the company. HC Wainwright reiterated a "buy" rating and issued a $20.00 target price on shares of Aspen Aerogels in a report on Wednesday, February 14th. TheStreet upgraded Aspen Aerogels from a "d+" rating to a "c-" rating in a report on Wednesday, March 6th. Finally, Canaccord Genuity Group lifted their target price on Aspen Aerogels from $13.00 to $17.00 and gave the stock a "buy" rating in a report on Wednesday, December 27th. One analyst has rated the stock with a sell rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Moderate Buy" and an average target price of $19.00.
Get Our Latest Report on Aspen Aerogels
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
See Also
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
